JP2013515742A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515742A5
JP2013515742A5 JP2012546222A JP2012546222A JP2013515742A5 JP 2013515742 A5 JP2013515742 A5 JP 2013515742A5 JP 2012546222 A JP2012546222 A JP 2012546222A JP 2012546222 A JP2012546222 A JP 2012546222A JP 2013515742 A5 JP2013515742 A5 JP 2013515742A5
Authority
JP
Japan
Prior art keywords
formulation
terbinafine
preparation
short
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012546222A
Other languages
English (en)
Japanese (ja)
Other versions
JP5829217B2 (ja
JP2013515742A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/061940 external-priority patent/WO2011079234A2/en
Publication of JP2013515742A publication Critical patent/JP2013515742A/ja
Publication of JP2013515742A5 publication Critical patent/JP2013515742A5/ja
Application granted granted Critical
Publication of JP5829217B2 publication Critical patent/JP5829217B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012546222A 2009-12-23 2010-12-22 高浸透性テルビナフィン製剤 Expired - Fee Related JP5829217B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28996709P 2009-12-23 2009-12-23
US28996209P 2009-12-23 2009-12-23
US61/289,962 2009-12-23
US61/289,967 2009-12-23
PCT/US2010/061940 WO2011079234A2 (en) 2009-12-23 2010-12-22 Highly permeating terbinafine formulation

Publications (3)

Publication Number Publication Date
JP2013515742A JP2013515742A (ja) 2013-05-09
JP2013515742A5 true JP2013515742A5 (enExample) 2014-02-13
JP5829217B2 JP5829217B2 (ja) 2015-12-09

Family

ID=43770418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546222A Expired - Fee Related JP5829217B2 (ja) 2009-12-23 2010-12-22 高浸透性テルビナフィン製剤

Country Status (7)

Country Link
US (1) US9084754B2 (enExample)
EP (1) EP2544659A2 (enExample)
JP (1) JP5829217B2 (enExample)
CN (1) CN102770123A (enExample)
AU (1) AU2010336441B2 (enExample)
CA (1) CA2785643A1 (enExample)
WO (1) WO2011079234A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012107565A1 (en) 2011-02-11 2012-08-16 Moberg Derma Ab Novel antifungal composition
JP6339940B2 (ja) * 2011-12-20 2018-06-06 ビョーメ バイオサイエンシズ ピーブイティー．リミテッド 真菌感染症の治療用の局所用オイル組成物
EP2664327A1 (en) * 2012-05-14 2013-11-20 Almirall S.A. Topical pharmaceutical compositions comprising terbinafide and urea
NL2009669C2 (en) * 2012-10-19 2014-04-23 Dutch Renewable Energy B V Enhanced nail penetrating composition.
TW201431572A (zh) 2012-12-21 2014-08-16 Teikoku Pharma Usa Inc 荷爾蒙及其它醫藥劑之經皮傳遞的組成物及方法
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP2952208A1 (en) * 2014-06-04 2015-12-09 Universidade de Santiago de Compostela Hydroalcoholic system for nail treatment
DK3209319T3 (da) 2014-10-21 2021-10-04 Hexima Ltd En fremgangsmåde til behandling af svampeinfektioner
KR101690765B1 (ko) * 2015-04-17 2016-12-28 동아제약 주식회사 항진균성 활성물질을 포함하는 경피 제제
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
WO2017031075A1 (en) * 2015-08-17 2017-02-23 Arno Therapeutics, Inc. Methods and compositions for enhanced transungual delivery of ar-12
EP3359133B1 (en) * 2015-10-07 2024-05-01 Exodos Life Sciences LP Topical antifungal compositions
GB201605127D0 (en) * 2016-03-25 2016-05-11 Blueberry Therapeutics Ltd Composition and methods of treatment
BR112018075998A2 (pt) * 2016-06-13 2019-04-02 Vyome Therapeutics Limited. composições antifúngicas sinérgicas e métodos das mesmas
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
JP7176760B2 (ja) 2016-11-28 2022-11-22 セリックス バイオ プライヴェート リミテッド 真菌感染の処置のための組成物及び方法
WO2019214838A1 (en) * 2018-05-09 2019-11-14 Eviderm Institute Ab Use of an alcohol-containing composition for improving the skin barrier function
WO2019234546A1 (en) * 2018-06-04 2019-12-12 Zenvision Pharma Llp Antifungal cuticle oil composition
EP3603650A1 (fr) 2018-08-01 2020-02-05 Edix O Sarl Compositions injectables et a duree d'action prolongee pour leur utilisation dans le traitement de maladies de l'ongle et/ou pour accelerer la croissance de l'ongle
CN112888443A (zh) 2018-08-01 2021-06-01 爱迪克斯-欧有限公司 用于其在治疗指或趾甲疾病中的使用和/或用于加速指或趾甲生长的具有延长的作用持续时间的可注射组合物
CN113208937A (zh) * 2020-01-21 2021-08-06 中国医学科学院北京协和医院 一种角质软化组合物及其制备方法和应用及治疗灰指甲的外用复方及其制备方法和应用
JP7664026B2 (ja) * 2020-08-06 2025-04-17 沢井製薬株式会社 エフィナコナゾール含有爪外用液
CN113234028B (zh) * 2021-04-29 2022-08-26 上海大学 一种5-氟尿嘧啶与肌氨酸的共晶体及其制备方法与用途
CN113786382B (zh) * 2021-11-04 2024-05-28 浙江得恩德制药股份有限公司 一种盐酸特比萘芬凝胶及制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
IT1180295B (it) 1984-10-08 1987-09-23 Durst Phototechnik Srl Ingranditore o riproduttore fotografico a colori
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
IL132682A (en) 1997-05-14 2004-06-20 Galen Chemicals Ltd Medicinal preparations for topical treatment
WO1999053913A1 (en) * 1998-04-17 1999-10-28 Bertek Pharmaceuticals, Inc. Topical formulations for the treatment of nail fungal diseases
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
IL160550A0 (en) 2001-09-04 2004-07-25 Trommsdorff Arzneimittel Plaster for the treatment of dysfunctions and disorders of nail growth
US20030091666A1 (en) * 2001-11-14 2003-05-15 Howard Murad Methods and compositions for treating dermatological disorders with Morinda citrifolia
US7138394B2 (en) 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
WO2005018530A2 (en) 2003-08-25 2005-03-03 Foamix Ltd. Penetrating pharmaceutical foam
JP4540667B2 (ja) * 2003-03-21 2010-09-08 ネクスメツド・ホールデイングス・インコーポレイテツド 抗真菌性ネイルコート
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078599A1 (en) 2004-10-12 2006-04-13 Mathew Ebmeier Pharmaceutical composition applicable to body tissue
CA2500907A1 (en) 2005-03-15 2006-09-15 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
EP1858556A1 (en) 2005-03-16 2007-11-28 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
GB0511499D0 (en) * 2005-06-06 2005-07-13 Medpharm Ltd Topical ungual formulations
US20070224261A1 (en) 2006-03-22 2007-09-27 Peter Draper Eutectic liquid drug formulation
US8431140B2 (en) * 2006-06-14 2013-04-30 Dr. Reddy's Laboratories, Inc. Topical compositions
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
JP2011529038A (ja) * 2008-07-23 2011-12-01 ターゲッティド デリバリー テクノロジーズ リミテッド 真菌感染症の処置のための局所抗真菌製剤の投与方法
WO2011014850A2 (en) * 2009-07-31 2011-02-03 Nuvo Research Inc. Topical eutectic-based formulations

Similar Documents

Publication Publication Date Title
JP2013515742A5 (enExample)
ES2631953T3 (es) Composición para aplicación tópica, sus usos, dispositivo de aplicación y kit de partes
JP2016508158A5 (enExample)
JP2011140525A5 (enExample)
WO2012085523A3 (en) Skin sanitizer compositions comprising alcohol based emulsion
WO2011079234A3 (en) Highly permeating terbinafine formulation for treating onychomycosis
DOP2013000125A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso.
SG10201400685SA (en) Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia
JP2011116787A5 (enExample)
HRP20171512T1 (hr) Derivati betulina
WO2014067986A8 (en) Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
PH12015500930A1 (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
HK1198921A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
WO2010101742A3 (en) Ampholytic ter-polymers for use in personal care compositions
MY165003A (en) Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
BR112012019374A2 (pt) composição farmacêutica, pellet de liberação prolongada, composição farmacêutica oral, método para tratamento de uma doença neurodegenerativa ou um dano ao sistema nervoso em um indivíduo necessitado do mesmo e método para preparação de uma formulação de liberação prolongada de um agente ativo
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof
NZ592647A (en) Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
RU2009101326A (ru) Препарат для наружного применения на кожу, содержащий тритерпеновую кислоту
NZ596228A (en) Compositions and methods for the treatment of inflammation
ME02147B (me) Jedinjenje sa topikalnom primjenom za aktinične keratoze
TW201129396A (en) Topical formulation
CR20140053A (es) Formulaciones de ácido desoxicólico y sales del mismo
BR112013000613A2 (pt) composições secas e dispositivos que contêm tais composições secas
WO2011134979A3 (en) Stable aqueous mia/cd-rap formulations